In this webinar, hosted by Revvity, two distinguished Professors provide insight into their experiences of LTBI screening, and the importance of choosing the right IGRA methodology. This is your opportunity to delve deeper, to understand not just the what, but the how and why.
Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ
Professor of Medicine; Chair of the Department of Infectious Diseases, Infection Control, and Employee Health; and Director of the Clinical Virology Research Program
University of Texas MD Anderson Cancer Center, Houston, TX
James Galloway
Professor of Rheumatology and Deputy Head of the Centre for Rheumatic Diseases
King’s College, London
To view this webinar, please complete the following form.
2024 EUROIMMUN US
